| Literature DB >> 32375659 |
Ivan Buljan1,2, Ružica Tokalić3,4, Marija Roguljić5, Irena Zakarija-Grković3,4, Davorka Vrdoljak6, Petra Milić7, Livia Puljak8, Ana Marušić3,4.
Abstract
BACKGROUND: Cochrane systematic review Plain language Summaries (CSR PLSs should serve as a tool for the evidence translation to non-medical population. However, the evidence of optimal type of numerical presentation in CSR PLSs is still scarce. The aim of this study was to investigate readers' comprehension and preferences for different presentation of findings, including framing and numerical data, in Cochrane systematic review Plain Language Summaries (CSR PLSs).Entities:
Keywords: Evidence summaries; Health numeracy; Information translation; Plain language summaries
Mesh:
Year: 2020 PMID: 32375659 PMCID: PMC7201737 DOI: 10.1186/s12874-020-00990-4
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Fig. 1Flowchart of participants in both trials
Sample characteristics in two randomized trials of summary format testing
| Trials | Trial 1. Framing | Trial 2. Numerical presentation | ||
|---|---|---|---|---|
| Variables | Negative ( | Positive ( | Group A ( | Group B ( |
| 44 (100) | 47 (100) | 52 (44.1) | 43 (46.7) | |
| 32 (72.2) | 33 (70.2) | 75 (62.5) | 83 (66.4) | |
| 19 (19.0 to 19.8) | 19 (19.0 to 20.0) | 28.5 (21.0 to 47.5) | 33.0 (22.0 to 55.0) | |
| Elementary | 0 | 0 | 1 (0.8) | 2 (1.6) |
| High school | 0 | 0 | 22 (18.3) | 33 (26.4) |
| Currently enrolled in university | 44 (100) | 47 (100) | 55 (45.8) | 47 (37.6) |
| College graduate | 0 | 0 | 8 (6.7) | 24 (19.2) |
| University graduate | 0 | 0 | 33 (27.5) | 19 (19.2) |
| PhD | 0 | 0 | 1 (0.8) | 0 |
| Internet | 27 (61.4) | 34 (72.3) | 90 (75.0) | 95 (76.0) |
| Family and friends | 16 (36.4) | 17 (36.2) | 39 (32.5) | 54 (43.2) |
| Books | 12 (27.3) | 11 (23.4) | 48 (40.0) | 42 (33.6) |
| Family doctor | 31 (70.5) | 29 (61.7) | 78 (65.0) | 85 (68.0) |
| First page of search results | 17 (38.6) | 16 (34.0) | 40 (33.3) | 58 (46.4) |
| Online forums | 19 (43.2) | 19 (40.4) | 38 (31.7) | 43 (34.4) |
| Hospital websites | 9 (20.5) | 19 (40.4) | 20 (16.7) | 18 (14.4) |
| Local specialized websites | 13 (29.5) | 14 (29.8) | 30 (25.4) | 32 (34.8) |
| International specialized articles | 5 (11.4) | 11 (23.4) | 23 (19.2) | 13 (10.4) |
| Research articles | 4 (9.1) | 8 (17.0) | 30 (25.0) | 19 (15.2) |
| Email to physicians on Internet websites | 1 (2.3) | 4 (8.5) | 4 (3.3) | 1 (0.8) |
| 0.0 (0.0 to 1.0) | 0.0 (−2.3 to 1.5) | |||
| 5.0 (4.0–5.0) | 5.0 (4.0–5.0) | 3.0 (2.0 to 4.0) | 3.0 (2.0 to 4.0) | |
Md median; IQR interquartile range
aMultiple entries allowed
bOne item scale, ranging from −4 (indicating absolute preference towards words in presentation of health information) to + 4 (indicating absolute preference towards numbers in presentation of health information)
cThe scale was calculated as the sum of correct answers, range from 0 to 5
Perceived effectiveness, desire for prescription and readiness to use the described treatment between groups that read positively and negatively framed Cochrane PLSs among a student population (N = 91)
| Variables | Framing (mean, 95% CI) | Mean difference (95% CI) | BF | |
|---|---|---|---|---|
| Negative ( | Positive ( | |||
| Perceived effectiveness of treatment (score 3–30) | 17.3 (15.8 to 18.8) | 15.8 (14.6 to 17.0) | 1.53 (−0.33 to 3.39) | 1.31 × 10− 4 |
| Desire that treatment be prescribed by family doctor (score 3–30) | 16.1 (14.8 to 17.3) | 15.4 (14.2 to 16.6) | 0.69 (−1.00 to 2.37) | 0.036 |
| Readiness to use the treatment (score 3–30) | 17.1 (15.8 to 18.4) | 16.6 (15.2 to 18.0) | 0.52 (−1.39 to 2.43) | 0.035 |
| Comprehension (score 0–12) | 8.6 (8.0 to 9.3) | 9.2 (8.6 to 9.7) | −0.51 (−1.43 to 0.35) | 1.81 × 10− 4 |
Comprehension score, perceived effectiveness of treatment, desire that treatment be prescribed by the family doctor and readiness to use the treatment were calculated as the sum of correct answers for three PLSs. CI – confidence interval
aBayesian t-test for independent samples
Participants’ comprehension of Cochrane PLSs between groups A and B
| Mean (95% CI) | |||||||
|---|---|---|---|---|---|---|---|
| Group A | Group B | ||||||
| Comprehension: Results (score 0–2) | 1.41 (1.27 to 1.55) | 1.62 (1.50 to 1.73) | 1.63 (1.52 to 1.71) | 1.66 (1.56 to 1.75) | 1.06 | 0.78 | 0.62 |
| Comprehension: Side effects (score 0–2) | 1.18 (1.05 to 1.30) | 1.14 (1.01 to 1.26) | 1.53 (1.40 to 1.66) | 1.50 (1.38 to 1.63) | 0.14 | 0.13 | |
Comprehension score is calculated as the sum of correct answers to questions in one PLS focused on benefits or side effects of a treatment. Each PLS had 4 questions, two focusing on benefits and two on side effects. CI – confidence interval, PLS – plain language summary
aBayesian repeated measures ANOVA comparison of PLS 1 and PLS 2
bBayesian repeated measures ANOVA, between subject effects analysis; Group
cBayesian repeated measures ANOVA interaction of effects of PLS and Group
Consumers’ and biomedical students’ answers on comprehension, perceived effectiveness of the described treatment and preference for health information presentation in Cochrane PLSs (N = 245)
| Mean (95% CI) | |||||||
|---|---|---|---|---|---|---|---|
| Consumers ( | Biomedical students ( | ||||||
| Comprehension: Results (score 0–2) | 1.43 (1.31 to 1.55) | 1.59 (1.50 to 1.69) | 1.66 (1.53 to 1.80) | 1.71 (1.59 to 1.82) | 1.07 | 2.43 | 0.26 |
| Comprehension: Side effects (score 0–2) | 0.93 (0.83 to 1.04) | 1.35 (1.23 to 1.49) | 1.51 (1.38 to 1.63) | 1.77 (1.65 to 1.89) | 0.45 | ||
| Perceived effectiveness of treatment (score 1–10) | 4.53 (4.12 to 4.96) | 4.93 (4.48 to 5.34) | 4.84 (4.44 to 5.24) | 5.35 (4.97 to 5.73) | 0.50 | 0.17 | |
| Preference for health information presentation (score 1–10) | 6.04 (5.65 to 6.52) | 6.06 (5.60 to 6.53) | 5.47 (5.03 to 5.92) | 5.78 (5.39 to 6.16) | 0.45 | 0.62 | 0.26 |
Comprehension score is calculated as the sum of correct answers to questions in a PLS focused on the benefits or side effects of treatment. Each PLS had 4 questions, two focusing on benefits and two on side effects. CI confidence interval, PLS plain language summary
aRepeated measures ANOVA comparison of PLS 1 and PLS 2
bRepeated measures analysis, between subject effects analysis Sample
cRepeated measures ANOVA interaction of effects of PLSs and Sample